Introduction {#sec1_1}
============

Psoriasis is a chronic inflammatory disease that affects genetically susceptible people and is triggered by environmental factors and immune disorders. Such triggers might include drugs, infections, and electrolyte disorders. It is characterized by recurrent skin disorder, histologically described as cutaneous inflammation, increased epidermal proliferation, hyperkeratosis, angiogenesis, abnormal keratinization, shortened maturation time, and parakeratosis. Psoriasis has many variants with cutaneous and extracutaneous manifestations. Generalized pustular psoriasis (GPP) is frequently associated with systemic symptoms.

Adult hypoparathyroidism is caused mainly by surgical complications, especially following thyroidectomy, with the risk of severe hypocalcemia. Its presentation may be asymptomatic or associated with several types of clinical features that appear abruptly or chronically \[[@B1],[@B2]\]. One of the most specific manifestations of acute hypocalcemia is tetany related to neuromuscular irritability. However, many other manifestations have been attributed to hypocalcemia, including GPP \[[@B3],[@B4]\]. Intracellular calcium plays an important role in regulating the proliferation and differentiation of keratinocytes. Some case reports have described psoriasis associated with disorders of calcium metabolism \[[@B5]\]. We here present a case of hypoparathyroidism as a trigger for severe acute GPP with life-threatening complications.

Case Report {#sec1_2}
===========

A 73-year-old female patient, retired, was transferred to our institution for a diagnostic evaluation of diffuse erythrodermia 1 month before internment. The patient reported that the first lesions appeared as little periumbilical pruritic pustules. These lesions evolved to bullous lesions, with subsequent hyperkeratosis and desquamation, spreading to the extremities, the trunk and the face, associated with daily unmeasured fever, generalized edema, resting tremor, dyspnea and a decrease in her general state of health.

She denied mucosal involvement, similar previous episodes or recent exposure to new drugs/medicines. Her past medical history was related to systemic essential hypertension, well controlled with losartan, and total thyroidectomy 10 years ago, with irregular use of levothyroxine.

On admission, the patient was in a regular general state of health, with hypochromic mucous membranes, sinus tachycardia, and discrete tachypnea. Physical examination revealed diffuse crackles and wheezing, muscle weakness at the pelvic and shoulder girdle of grade 1 of 5, and resting tremor of the hands. There were no other movement disorders or ocular alterations. The skin showed erythrodermic lesions with disseminated desquamation (fig. [1](#F1){ref-type="fig"}), and discrete pustular lesions on the upper limbs without mucous lesions. Onycholysis was present associated with the destruction of the nail bed of the hands.

Liver enzymes, renal function and urinalysis were normal. Complete blood count showed anemia of chronic disease and mild leukocytosis. The remaining laboratory examinations showed hypoalbuminemia of 2.5 g/dl, creatine phosphokinase of 500 IU/l, erythrocyte sedimentation rate of 80 mm/h, and severe hypocalcemia (total calcium 3.5 mEq/dl).

Noteworthy was the hormonal panel: TSH = 12.27 μIU/ml, free T4 = 1.1 ng/dl, cholecalciferol = 34.6 ng/ml, and parathyroid hormone = 13 pg/ml. There was no monoclonal gammopathy found at protein electrophoresis. Anti-HIV-I, anti-HIV-II, anti-HTLV-I, anti-HTLV-II, VDRL, and antinuclear antibodies were negative.

The echocardiogram showed signs of dilated cardiomyopathy with diffuse hypokinesia and an ejection fraction of 28%, without significant valve disease or segmental abnormalities. Chest X-ray was unremarkable except for congestive signs. A thigh skin biopsy was performed for diagnostic purpose, with histopathological findings consistent with pustular psoriasis (fig. [2](#F2){ref-type="fig"}).

The patient was treated with intravenous calcium and cholecalciferol, with regular use of oral levothyroxine. She progressed with significant improvement of her symptoms, with complete remission of the skin changes (fig. [3](#F3){ref-type="fig"}) and progressive improvement of her heart function.

Before discharge, another echocardiogram was performed showing complete recovery of the heart function, reinforcing the hypothesis of cardiomyopathy induced by GPP. All altered laboratory examinations returned to normal ranges. The clinical and the dermatology team decided to initiate methotrexate after the clinical improvement. The patient was referred to ambulatory follow-up.

Discussion {#sec1_3}
==========

Psoriasis is a chronic inflammatory disease characterized by a dysregulation of immunity in genetically predisposed persons. The prevalence of the disease increases with the distance from the equator line \[[@B6],[@B7],[@B8],[@B9],[@B10]\].

Classically, psoriasis presents as chronic plaques with a variable extent of skin involvement. The diagnosis is eminently clinical; however, less common variants may require a histopathological study. Early alterations are seen on the papillary dermis, where there are perivascular infiltrations with vasodilation followed by epidermic alterations like acanthosis and parakeratosis \[[@B10]\].

Among other variants of psoriasis, the pustular form presents itself in many ways: GPP, impetigo herpetiformis, and two variants of localized pustular psoriasis (palmoplantar pustulosis and acrodermatitis continua of Hallopeau) \[[@B10],[@B11]\].

Considering the patient\'s initial presentation of generalized pustulosis, two conditions must be investigated as possible mimickers of GPP: Sneddon\'s disease and acute generalized exanthematous pustulosis.

The main suspected diagnosis was GPP, since no monoclonal gammopathy was found, and she denied any use of medications usually associated with acute generalized exanthematous pustulosis (e.g. antimalarial). GPP was confirmed by histopathologic findings.

Interestingly, she presented with signs of heart failure and moderate hypoalbuminemia which are known as extracutaneous manifestations of severe GPP \[[@B9],[@B10],[@B12],[@B13],[@B14]\].

Myopathy was considered as part of hypothyroidism manifestations. The negative antinuclear antibodies with the absence of classic cutaneous findings of dermatomyositis and nearly normal creatine phosphokinase ruled out this hypothesis.

The most remarkable laboratory finding was severe hypocalcemia, justifying her resting tremor and possible association with severe psoriasis. All of this confirmed the diagnosis of severe GPP triggered by hypocalcemia related to untreated hypoparathyroidism after total thyroidectomy.

The GPP variant is usually preceded by other forms of psoriasis and has particular aspects on pathogenesis like mutations of the IL36RN gene. This gene codifies the receptor antagonist of interleukin-36 and has been associated with mucous lesions \[[@B15],[@B16],[@B17]\].

Many triggers for GPP have been described, especially gestation, infections, and drugs like glucocorticoids, amoxicillin and pegylated interferon. This case shows that the clinician must be aware of uncommon triggers like hypocalcemia. This electrolyte imbalance may present as a cause and consequence of disseminated disease, and the correct diagnosis is important to initiate early therapeutic intervention \[[@B4],[@B12],[@B18],[@B19]\].

GPP is one of the most serious variants of psoriasis, since it is usually not restricted to the skin and has variable systemic manifestations. Clinically, GPP has two forms: acute GPP of von Zumbusch and generalized annular pustular psoriasis. The von Zumbusch GPP type is characterized by disseminated pustules on the trunk, extremities, and palmar-plantar regions that coalesce and then resolve, leaving erythema and extensive scaling.

Sometimes the diagnosis is difficult to make because the pustules are not present at the moment of examination, when only diffuse erythrodermia may be evident. GPP is one of the most serious variant of psoriasis because of life-threatening systemic complications including capillary leak syndrome, heart failure, acute respiratory distress syndrome, and sepsis \[[@B9],[@B10],[@B11]\].

Laboratory alterations compatible with systemic inflammation, such as leukocytosis, high erythrocyte sedimentation rate, hypoalbuminemia, and hepatic enzymes elevation, are common in GPP.

Hypocalcemia may be cause or consequence of the von Zumbusch psoriasis \[[@B9],[@B10],[@B20]\]. Many studies suggest that vitamin D plays a role in cell differentiation and proliferation of the skin. Furthermore, cell adhesion needs cadherins, which are molecules that depend on calcium \[[@B5],[@B21],[@B22]\]. These physiologic aspects may justify how some patients with hypoparathyroidism may precipitate psoriasis, including GPP, as presented here.

Different treatment options must be offered besides the classical therapy with oral retinoids, methotrexate, TNF-α blockers, and cyclosporine to treat GPP triggered by hypocalcemia. Calcium reposition associated with D vitamin is part of the essential treatment of acute GPP when hypocalcemia is identified \[[@B3],[@B18],[@B22]\]. Nevertheless, some patients, even with resolution of the triggers, need immunosuppressive therapy to reduce relapse rates.

We presented a case of acute GPP triggered by hypocalcemia related to primary hypoparathyroidism after total thyroidectomy. First, we emphasize the importance of the patient\'s history and a thorough physical examination, since the pustules may not be present at the physical examination. Second, one should be aware that psoriasis is not only a skin disease, but also a systemic inflammatory condition with variable manifestations. Finally, we point out that hypocalcemia is a trigger of GPP. Due to this situation, the physician should aggressively replenish calcium and vitamin D.
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![Diffuse exfoliative lesions on the legs.](cde-0007-0345-g01){#F1}

![**a** Epidermis with acanthosis, parakeratosis and moderate perivascular inflammatory infiltrate in the superficial dermis. **b** Higher magnification showing epidermis with exocytosis of neutrophils and small pustule formation in the stratum corneum.](cde-0007-0345-g02){#F2}

![**a** Intense facial hyperkeratosis as a clinical manifestation of acute GPP. **b** Improvement of facial hyperkeratosis after treatment of hypocalcemia.](cde-0007-0345-g03){#F3}
